BioMarin Pharmaceutical Inc (BMRN) stock
BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30104% above fair value
$61.43+2.92 (+4.99%)
Close on Nov 18, 2026Market cap $11.89BP/E 161.7Yield –
BioMarin Pharmaceutical price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
BioMarin Pharmaceutical's price to book ratio was 1.8× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 1.7× to 4.7×, with a median of 3.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.8× | −0.1 |
| 2025 | Dec 31, 2025 | 1.9× | −0.4 |
| 2024 | Dec 31, 2024 | 2.3× | −1.4 |
| 2023 | Dec 29, 2023 | 3.7× | −0.5 |
| 2022 | Dec 30, 2022 | 4.2× | +0.4 |
| 2021 | Dec 31, 2021 | 3.8× | −0.1 |
| 2020 | Dec 31, 2020 | 3.9× | −1.0 |
| 2019 | Dec 31, 2019 | 4.9× | −0.3 |
| 2018 | Dec 31, 2018 | 5.2× | −0.4 |
| 2017 | Dec 29, 2017 | 5.6× | +0.2 |
| 2016 | Dec 30, 2016 | 5.4× | −2.0 |
| 2015 | Dec 31, 2015 | 7.4× | −1.5 |
| 2014 | Dec 31, 2014 | 8.8× | +1.0 |
| 2013 | Dec 31, 2013 | 7.8× | +1.8 |
| 2012 | Dec 31, 2012 | 6.0× | +0.9 |
| 2011 | Dec 30, 2011 | 5.1× | +0.4 |
| 2010 | Dec 31, 2010 | 4.7× | −2.3 |
| 2009 | Dec 31, 2009 | 7.0× | – |
See a number that looks wrong?